share_log

Tenax Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(10.0%),Janus Henderson Biotech Innovation Master Fund Ltd(10.0%)

SEC ·  Nov 15, 2024 01:42
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more